You are here: Home > Products >

Cell-Based Validation Services

– To validate ORF cDNA expression, shRNA knockdown, miRNA target or promoter activity

GeneCopoeia provides cell-based validation services to help researchers to validate the function and performance of expression clones using standard cell lines or customer’s own cell lines.

No matter you are studying transgene overexpression (ORF cDNA clones), gene knockdown (shRNA clones), transcription regulation in the promoter region (promoter reporter clones), or translation regulation by microRNA (microRNA target clones), GeneCopoeia’s expression clone collections and cell-based validation services are powerful tools to support your functional genomic research.

GeneCopoeia's cell-based validation services cover ORF cDNA clone expression validation, shRNA knockdown validation, miRNA target validation and promoter activity validation.

Advantages

Request a Quote
  • Largest clone collections to best suit your needs
  • Strict and rigorous experiment protocol to ensure quality results
  • Detailed reports and datasheets to assist decision making
  • Complete services to support your research needs

 

GeneCopoeia’s cell-based validation services include:

ORF cDNA clone expression validation
shRNA knockdown validation
miRNA target validation
Promoter activity validation
Detect recombinant protein expression in mammalian cells or bacteria using western blot.

Measure the efficiency of shRNA knockdown of GOI on the messenger-RNA level using qRT-PCR.

Validate the inhibitory effect of a particular miRNA on the 3’UTR region of GOI using luciferase reporter assays.

Detect exogenous promoter activation in mammalian cells using luciferase reporter assays.

 

Largest clone collections to best suit your needs

OmicsLink™ Expression-ready ORF cDNA Clones

OmicsLink™ shRNA clone collections

miTarget™ 3’UTR miRNA Target Clones

miExpress™ Precursor miRNA Expression Clones

miArrest™ miRNA Inhibitors

Gluc-ON™ Promoter Reporter Clones

 

 

Examples

ORF

Method:
Western Blot

Figure 1. Secreted TPP1 recombinant protein expression in 293 cells.TPP1 protein was secreted into the culture medium 48hrs after transient transfection with TPP1 expression clone (Z5873). The culture media (15uL per lane) were collected, resolved using10% SDS-PAGE/Tris-Glycine, transferred to a NC membrane, and probed with the anti-Flag antibody (CGAB-DDK-0050). A) The NC membrane was stained with Ponceau S. B) The western blot results were visualized with a chromogenic substrate. The culture medium of HEK293T cells without transfection was used as the negative control (lane 1).

shRNA

Method:
qRT-PCR

Figure 2. CD44 knocked down by 4 different shRNAs in HEK 293Ta cells. The HEK 293Ta cells were transfected with 1) shRNA scrambled control, 2) shRNA-1 (HSH022976-1-nH1), 3) shRNA-2 (HSH022976-2-nH1), 4) shRNA-3 (HSH022976-3-nH1), and 5) shRNA-4 (HSH022976-4-nH1), respectively. Total RNAs were extracted from each sample and quantified by qRT-PCR using CD44 specific primers. GAPDH(NM_002046)expression was also quantified and used for normalization. The normalized CD44 expression was set to 1 for the scrambled control transfected sample (first left bar). The results show that the shRNAs knocked down the CD44 mRNA expression level by 79% (HSH022976-1), 36% (HSH022976-2), 68% (HSH022976-3), and 56% (HSH022976-4) respectively. 

miRNA

Method:
Luciferase Reporter Assays

Figure 3. The suppression effect of miR-125a on LIN28 3’UTR target reporter expression in HEK 293 cells. LIN28 is the known target gene for miR-125a. A LIN28 3’UTR target sequence expression clone (HmiT019205-MT05) was transfected into HEK 293 cells 1) alone 2) with miR-125a miRNA precursor expression clone (HmiR0309-MR03) 3) with miR-125a miRNA precursor expression clone and miRNA inhibitor scrambled control clone (CmiR-AN0001-AM03) 4) with miR-125a miRNA precursor expression clone and miR-125a miRNA inhibitor clone (HmiR-AN0094-AM01). Both the Gaussia luciferase (GLuc) activity and an internal control Alkaline Phosphatase (AP) activity were determined 24 hours post-transfection. The activity ratio of GLuc to AP was set to 1 for the single transfection sample with LIN28 3'-UTR target sequence expression clone (left-most bar), against which the activities of other samples were normalized. The result shows that mir-125a suppressed the luciferase activity from the Gluc-LIN28-3'-UTR clone by more than 70% (Bar 2 from left). This suppression effect was blocked by the introduction of miArrest™ inhibitor clone against miR-125a (right-most bar) .

Promoter

Method:
Luciferase Reporter Assays

Figure 4: Normalized promoter activities in H1B1B and HEK293T cells. Dual-reporter promoter clones or controls were transfected into two cell lines in duplicates. Samples were analyzed 24 hrs (HEK293T) and 48 hrs (H1B1B) after transfection. NEG (containing non-promoter sequence) and EMPTY (no promoter in the vector) are negative controls.

 

 

Request a Quote

To request a quote for a cell-based validation service, please fill out the inquiry form here.

 

Related Services

Lentivirus packaging services

Delivering high titer lentivirus in either purified form.

Stable cell line development services

For stable cell-line development, gene amplification, single clone selection, cell line characterization and more.